Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder
Semi Helin, Tuomo Noppari, Lauri Nummenmaa, Lasse Lukkarinen et al.
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Topics
Autism Spectrum Disorder Research
article
Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder
Semi Helin, Tuomo Noppari, Lauri Nummenmaa, Lasse Lukkarinen, Hannu Lauerma, Pekka Tani, Jussi Hirvonen, Johan Rajander, Jouni Tuisku, Emma Saure, Nina Lindberg, Jari Tiihonen, Juha Salmi
article en
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Nuclear Medicine and Molecular ImagingVol. 53(3)
Institutions
Åbo Akademi University (FI), University of Helsinki (FI), University of Turku (FI), University of Eastern Finland (FI), Helsinki University Hospital (FI), Niuvanniemi Hospital (FI), Turku University Hospital (FI), Karolinska Institutet (SE), Turku PET Centre (FI), Hospital District of Helsinki and Uusimaa (FI), University of Oulu (FI)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder — Semi Helin, Tuomo Noppari, et al. · European Journal of Nuclear Medicine and Molecular Imaging (2025) | TGRS Research Map | TGRS